Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2013

Content (20 Articles)

Review

Myeloid-derived suppressor cells in breast cancer

Joseph Markowitz, Robert Wesolowski, Tracey Papenfuss, Taylor R. Brooks, William E. Carson III

Open Access Preclinical study

Inflammatory breast cancer (IBC): clues for targeted therapies

Sandra V. Fernandez, Fredika M. Robertson, Jianming Pei, Lucy Aburto-Chumpitaz, Zhaomei Mu, Khoi Chu, R. K. Alpaugh, Yong Huang, Yu Cao, Zaiming Ye, Kathy Q. Cai, Kimberly M. Boley, Andres J. Klein-Szanto, Karthik Devarajan, Sankar Addya, Massimo Cristofanilli

Preclinical Study

Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells

Tatjana Kaiser, Ingrid Teufel, Konstanze Geiger, Yvonne Vater, Wilhelm K. Aicher, Gerd Klein, Tanja Fehm

Preclinical study

Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer

Yunli Zhou, Lili Zhao, Tie Xiong, Xiaojun Chen, Yongci Zhang, Man Yu, Jie Yang, Zhi Yao

Open Access Preclinical Study

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

E. H. Lips, L. Mulder, J. J. de Ronde , I. A. M. Mandjes, B. B. Koolen, L. F. A. Wessels, S. Rodenhuis, J. Wesseling

Clinical trial

A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer

R. Charles Coombes, Fatima Cardoso, Nicolas Isambert, Thierry Lesimple, Patrick Soulié, Concepcion Peraire, Veronique Fohanno, Anne Kornowski, Tauhid Ali, Peter Schmid

Open Access Clinical Trial

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

Salomon M. Stemmer, Shmuel H. Klang, Noa Ben-Baruch, David B. Geffen, Mariana Steiner, Lior Soussan-Gutman, Shahar Merling, Christer Svedman, Shulamith Rizel, Nicky Lieberman

Clinical trial

Cording following treatment for breast cancer

Jean O’Toole, Cynthia L. Miller, Michelle C. Specht, Melissa N. Skolny, Lauren S. Jammallo, Nora Horick, Krista Elliott, Andrzej Niemierko, Alphonse G. Taghian

Clinical Trial

Ultrasound-guided fine-needle aspiration of suspicious nodes in breast cancer patients; selecting patients with extensive nodal involvement

B. J. van Wely, J. H. W. de Wilt, P. J. C. Schout, B. Kooistra, C. A. P. Wauters, D. Venderinck, L. J. A. Strobbe

Open Access Clinical trial

Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT)

Rachel Y. Lei, Charles E. Leonard, Kathryn T. Howell, Phyllis L. Henkenberns, Timothy K. Johnson, Tracy L. Hobart, Shannon P. Fryman, Jane M. Kercher, Jodi L. Widner, Terese Kaske, Dennis L. Carter

Epidemiology

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

D. Gareth R. Evans, Sarah L. Ingham, Andrew Baildam, Gary L. Ross, Fiona Lalloo, Iain Buchan, Anthony Howell

Epidemiology

Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival

J. P. Bulte, B. J. van Wely, S. Kasper, G. Kuijt, F. J. H. van den Wildenberg, L. J. A. Strobbe, J. H. W. de Wilt

Epidemiology

Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility

Jibing Liu, Xiaohu Tang, Meng Li, Chao Lu, Juan Shi, Liqing Zhou, Qipeng Yuan, Ming Yang

Epidemiology

Weight, inflammation, cancer-related symptoms and health-related quality of life among breast cancer survivors

Ikuyo Imayama, Catherine M. Alfano, Marian L. Neuhouser, Stephanie M. George, Ashley Wilder Smith, Richard N. Baumgartner, Kathy B. Baumgartner, Leslie Bernstein, Ching-Yun Wang, Catherine Duggan, Rachel Ballard-Barbash, Anne McTiernan

Open Access Epidemiology

Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa

Herbert Cubasch, Maureen Joffe, Rachel Hanisch, Joachim Schuz, Alfred I. Neugut, Alan Karstaedt, Nadine Broeze, Eunice van den Berg, Valerie McCormack, Judith S. Jacobson

Brief Report

Providing access to risk prediction tools via the HL7 XML-formatted risk web service

Jonathan Chipman, Brian Drohan, Amanda Blackford, Giovanni Parmigiani, Kevin Hughes, Phil Bosinoff

Open Access Brief Report

Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers

Anita Bane, Alicia Viloria-Petit, Dushanthi Pinnaduwage, Anna Marie Mulligan, Frances P. O’Malley, Irene L. Andrulis

Brief Report

Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations

Luna Kadouri, Michal Sagi, Yael Goldberg, Israela Lerer, Tamar Hamburger, Tamar Peretz

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine